Teva Pharma (TEVA): Cutting PT, Possible Estimate Cut Coming - Wells Fargo
Tweet Send to a Friend
Wells Fargo analyst, David Maris, reiterated his Market Perform rating on shares of Teva Pharma (NYSE: TEVA) and cut his ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE